TIAZAC Side Effects

6727822-6 | Bunion, Fatigue, Oedema Peripheral, Toe Amputation
on Apr 29, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: bunion, fatigue, oedema peripheral, toe amputation. Tiazac dosage: 300 Mg (300 Mg, 1 In 1 D), Oral. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), DIGITEK (View Digitek Review and Digitek Label ), PLAVIX (View Plavix Review and Plavix Label ), POTASSIUM (View Potassium Review and Potassium Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CELEBREX (View Celebrex Review and Celebrex Label ), XANAX (View Xanax Review and Xanax Label ), PERCOCET (View Percocet Review and Percocet Label ).

6627838-4 | Blood Pressure Increased, Dizziness, Hyperhidrosis, Nausea
Patient was taking Tiazac (View Usage). Patient had the following side effects: blood pressure increased, dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?) on Mar 05, 2010 from UNITED STATES Additional patient health information: Female patient , 90 years of age, was diagnosed with hypertension and. Tiazac dosage: (1 In 1 D), Oral. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FOSAMAX (ALENDRONATE SODIUM) (ALENDRONATE SODIUM) (View Fosamax (alendronate Sodium) (alendronate Sodium) Review and Fosamax (alendronate Sodium) (alendronate Sodium) Label ), MULTIVITAMIN (NOS) (View Multivitamin (nos) Review and Multivitamin (nos) Label ), OMEGA 3 (FISH OIL) (FISH OIL) (View Omega-3 (fish Oil) (fish Oil) Review and Omega-3 (fish Oil) (fish Oil) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6627752-4 | Blood Pressure Increased, Dizziness, Hyperhidrosis, Nausea
Adverse event was reported on Mar 05, 2010 by a Female patient taking Tiazac (View Usage) (Dosage: (1 In 1 D), Oral) was diagnosed with hypertension and. Location: UNITED STATES , 90 years of age, After Tiazac was administered, patient had the following side effects: blood pressure increased, dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?). During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FOSAMAX (ALENDRONATE SODIUM) (ALENDRONATE SODIUM) (View Fosamax (alendronate Sodium) (alendronate Sodium) Review and Fosamax (alendronate Sodium) (alendronate Sodium) Label ), MULTIVITAMIN (NOS) (View Multivitamin (nos) Review and Multivitamin (nos) Label ), OMEGA 3 (FISH OIL) (FISH OIL) (View Omega-3 (fish Oil) (fish Oil) Review and Omega-3 (fish Oil) (fish Oil) Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6448139-3 | Dyspnoea, Fall, Heart Rate Decreased, Hypertension, Hypotension, Nervousness
on Sep 30, 2008 Female patient from UNITED STATES , 77 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, fall (What is fall?), heart rate decreased, hypertension, hypotension, nervousness. Tiazac dosage: 300 Mg (300 Mg, 1 In 1 D) Oral. During the same period patient was treated with BYSTOLIC (5 Mg (5 Mg, 1 In 1 D) Oral; 10 Mg (10 Mg, 1 In 1 D) Oral) (View Bystolic Review and Bystolic Label ), FLOVENT (INHALANT) (View Flovent (inhalant) Review and Flovent (inhalant) Label ), PROVENTIL (INHALANT) (View Proventil (inhalant) Review and Proventil (inhalant) Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CLARITIN (View Claritin Review and Claritin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).


6397709-X | Bradycardia
on Sep 22, 2009 Male patient from UNITED STATES , 80 years of age, was treated with Tiazac (View Usage). Patient had the following side effects: bradycardia. Tiazac dosage: 240 Mg. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DIURETICS (View Diuretics Review and Diuretics Label ).

6185780-X | Cerebrovascular Accident, Chest Discomfort, Headache, Hypoaesthesia, Middle Ear Effusion, Nasal Mucosal Disorder, Paraesthesia, Rash
Patient was taking Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: cerebrovascular accident, chest discomfort, headache (What is headache?), hypoaesthesia, middle ear effusion, nasal mucosal disorder, paraesthesia, rash (What is rash?) on May 01, 2009 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 229.0 lb, . Tiazac dosage: 180 Mg (180 Mg, 1 In 1 D), Oral; 240 Mg (240 Mg, 1 In 1 D), Oral. During the same period patient was treated with DILTIAZEM (Dosage Forms, Oral) (View Diltiazem Review and Diltiazem Label ), LIPITOR (View Lipitor Review and Lipitor Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BELLERGAL (View Bellergal Review and Bellergal Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), MAXZIDE (View Maxzide Review and Maxzide Label ), PREMARIN (View Premarin Review and Premarin Label ). Patient was hospitalized.

6162519-5 | Abdominal Pain Upper, Arthralgia, Dysphagia, Joint Swelling, Musculoskeletal Chest Pain
Adverse event was reported on Mar 26, 2009 by a Female patient taking Tiazac (View Usage) (Dosage: (240 Mg Qd Oral)) . Location: CANADA , 66 years of age, weighting 200.6 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, arthralgia, dysphagia, joint swelling, musculoskeletal chest pain. During the same period patient was treated with ALTACE (View Altace Review and Altace Label ), CANESTEN /00212501/ (View Canesten /00212501/ Review and Canesten /00212501/ Label ), EZETROL (View Ezetrol Review and Ezetrol Label ), NITROGEN LIQUID (View Nitrogen Liquid Review and Nitrogen Liquid Label ), LASIX (View Lasix Review and Lasix Label ), IMOVANE (View Imovane Review and Imovane Label ), PLAVIX (View Plavix Review and Plavix Label ), FLOVENT (View Flovent Review and Flovent Label ).

6154973-X | Abdominal Pain, Arthralgia, Dysphagia, Joint Swelling, Musculoskeletal Chest Pain
on Mar 26, 2009 Female patient from CANADA , 66 years of age, weighting 200.6 lb, was treated with Tiazac (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, dysphagia, joint swelling, musculoskeletal chest pain. Tiazac dosage: (240 Mg Qd Oral).

6138095-X | Abdominal Pain Upper, Arthralgia, Dysphagia, Joint Swelling, Musculoskeletal Chest Pain
on Mar 05, 2009 Female patient from CANADA , 66 years of age, weighting 200.6 lb, was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: abdominal pain upper, arthralgia, dysphagia, joint swelling, musculoskeletal chest pain. Tiazac dosage: (240 Mg Qd Oral). During the same period patient was treated with ALTACE (View Altace Review and Altace Label ), ARTHROTEC (View Arthrotec Review and Arthrotec Label ), CANESTEN /00212501/ (View Canesten /00212501/ Review and Canesten /00212501/ Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), ASPIRIN 10GR TIMED DISINTEGRATION TAB (View Aspirin 10gr Timed Disintegration Tab Review and Aspirin 10gr Timed Disintegration Tab Label ), FLOVENT (View Flovent Review and Flovent Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), IMDUR (View Imdur Review and Imdur Label ).

6088063-1 | Anxiety, Dyspnoea, Hyperhidrosis, Hypertension, Tachycardia
Patient was taking Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), dyspnoea, hyperhidrosis, hypertension, tachycardia on Feb 06, 2009 from CANADA Additional patient health information: Male patient , 54 years of age, . Tiazac dosage: (180 Mg, In The Evening Oral).

6077962-2 | Dyspnoea, Hyperhidrosis, Hypertension, Tachycardia
Adverse event was reported on Jan 27, 2009 by a Male patient taking Tiazac (View Usage) (Dosage: (180 Mg, In The Evening Oral)) . Location: CANADA , 54 years of age, Patient had the following side effects: dyspnoea, hyperhidrosis, hypertension, tachycardia.

6050767-4 | Cognitive Disorder, Dizziness, Headache, Memory Impairment, Psychomotor Retardation
on Jan 05, 2009 Male patient from CANADA , 77 years of age, was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: cognitive disorder, dizziness (What is dizziness?), headache (What is headache?), memory impairment, psychomotor retardation. Tiazac dosage: 180 Ml Qd.

6043574-X | Cardiogenic Shock, Dizziness, Heart Rate Decreased, Nausea
on Jan 05, 2009 Female patient from CANADA , 67 years of age, was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, dizziness (What is dizziness?), heart rate decreased, nausea (What is nausea?). Tiazac dosage: Dosage Forms (dosage Forms). During the same period patient was treated with METOPROLOL TARTRATE (Dosage Forms (dosage Forms)) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), CLODRONATE DISODIUM (View Clodronate Disodium Review and Clodronate Disodium Label ), COZAAR (View Cozaar Review and Cozaar Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6043333-8 | Blood Cholesterol Increased, Restless Legs Syndrome, Transient Ischaemic Attack
Patient was taking Tiazac (View Usage). Patient had the following side effects: blood cholesterol increased, restless legs syndrome, transient ischaemic attack on Jan 12, 2009 from UNITED STATES Additional patient health information: Female patient , 81 years of age, was diagnosed with hypertension, blood cholesterol increased and. Tiazac dosage: 240 Mg (240 Mg, 1 In 1 D, Oral. During the same period patient was treated with CRESTOR (20 Mg (20 Mg, 1 In 1 D), Oral) (View Crestor Review and Crestor Label ), DYAZIDE (TABLETS) (View Dyazide (tablets) Review and Dyazide (tablets) Label ), VYTORIN (View Vytorin Review and Vytorin Label ). Patient was hospitalized.

6037799-7 | Dizziness, Headache, Memory Impairment, Psychomotor Retardation, Unevaluable Event
Adverse event was reported on Jan 05, 2009 by a Male patient taking Tiazac (View Usage) (Dosage: 180 Ml Qd) . Location: CANADA , 77 years of age, After Tiazac was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), memory impairment, psychomotor retardation, unevaluable event. During the same period patient was treated with DIOVAN/01319601/ (View Diovan/01319601/ Review and Diovan/01319601/ Label ), ASPIRIN 10GR TIMED DISINTEGRATION TAB (View Aspirin 10gr Timed Disintegration Tab Review and Aspirin 10gr Timed Disintegration Tab Label ), REACTINE/00884301/ (View Reactine/00884301/ Review and Reactine/00884301/ Label ).

6012877-7 | Muscle Spasms, Restless Legs Syndrome, Transient Ischaemic Attack
on Dec 12, 2008 Female patient from UNITED STATES , 81 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms, restless legs syndrome, transient ischaemic attack. Tiazac dosage: 240 Mg (240 Mg, 1 In 1 D), Oral. During the same period patient was treated with DYAZIDE (TABLETS) (View Dyazide (tablets) Review and Dyazide (tablets) Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5959261-X | Blood Pressure Decreased, Fatigue
on Nov 03, 2008 Male patient from CANADA , 62 years of age, weighting 190.0 lb, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient had the following side effects: blood pressure decreased, fatigue. Tiazac dosage: .

5959013-0 | Dyspnoea, Fall, Heart Rate Decreased, Hypertension, Hypotension, Nervousness
Patient was taking Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: dyspnoea, fall (What is fall?), heart rate decreased, hypertension, hypotension, nervousness on Sep 03, 2008 from Additional patient health information: Female patient , 77 years of age, was diagnosed with hypertension and. Tiazac dosage: 300 Mg (300 Mg, 1 In 1 D), Oral. During the same period patient was treated with BYSTOLIC (5 Mg (5 Mg, 1 In 1 D), Oral) (View Bystolic Review and Bystolic Label ), FLOVENT (INHALANT) (View Flovent (inhalant) Review and Flovent (inhalant) Label ), PROVENTIL (INHALANT) (View Proventil (inhalant) Review and Proventil (inhalant) Label ), DYAZIDE( 37.5 MILLIGRAM) (View Dyazide( 37.5 Milligram) Review and Dyazide( 37.5 Milligram) Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CLARITIN (View Claritin Review and Claritin Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

5722264-4 | Erythema, Headache, Muscular Weakness, Skin Warm, Tachycardia
Adverse event was reported on Apr 09, 2008 by a Female patient taking Tiazac (View Usage) (Dosage: 240 Mg Qd At Bedtime Oral) . Location: CANADA , 59 years of age, Patient experienced the following unwanted or unexpected effects: erythema, headache (What is headache?), muscular weakness, skin warm, tachycardia. Patient was hospitalized.

5721213-2 | Cardiac Disorder, Cardiogenic Shock, Dizziness, Heart Rate Decreased, Nausea
on Apr 14, 2008 Female patient from UNITED STATES , 67 years of age, was treated with Tiazac (View Usage). Patient had the following side effects: cardiac disorder, cardiogenic shock, dizziness (What is dizziness?), heart rate decreased, nausea (What is nausea?). Tiazac dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), COZAAR (View Cozaar Review and Cozaar Label ), CLODRONATE (View Clodronate Review and Clodronate Label ), DIURETIC (NOS) (View Diuretic (nos) Review and Diuretic (nos) Label ).

5692857-1 | Asthenia, Erythema, Feeling Hot, Headache, Tachycardia
on Mar 17, 2008 Female patient from CANADA , 59 years of age, was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: asthenia, erythema, feeling hot, headache (What is headache?), tachycardia. Tiazac dosage: 240 Mg Qd At Bedtime Oral. Patient was hospitalized.

5642207-1 | Hypersensitivity
Patient was taking Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity on Feb 08, 2008 from UNITED STATES Additional patient health information: Female patient , 79 years of age, weighting 258.0 lb, was diagnosed with hypertension and. Tiazac dosage: 460 Mg Qd Po. During the same period patient was treated with ZESTRIL (20 Mg Qd) (View Zestril Review and Zestril Label ), LASIX (View Lasix Review and Lasix Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5580940-0 | Hypersensitivity
Adverse event was reported on Dec 21, 2007 by a Female patient taking Tiazac (View Usage) (Dosage: 460 Mg Qd Po) was diagnosed with hypertension and. Location: UNITED STATES , 79 years of age, weighting 258.0 lb, Patient had the following side effects: hypersensitivity. During the same period patient was treated with ZESTRIL (20 Mg Qd) (View Zestril Review and Zestril Label ), LASIX (View Lasix Review and Lasix Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5578122-1 | Bradycardia, Fatigue
on Dec 13, 2007 Female patient from CANADA , 73 years of age, weighting 170.0 lb, was diagnosed with hypertension and was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: bradycardia, fatigue. Tiazac dosage: (360 Mg Qd Oral).

5517845-7 | Dyspnoea, Hypersensitivity, Swollen Tongue, Throat Tightness
on Nov 01, 2007 Female patient from UNITED STATES , 80 years of age, weighting 258.0 lb, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypersensitivity, swollen tongue, throat tightness. Tiazac dosage: 460 Mg Qd Po. During the same period patient was treated with ZESTRIL (View Zestril Review and Zestril Label ), LASIX (View Lasix Review and Lasix Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

5444116-X | Cardiac Arrest
Patient was taking Tiazac (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?) on Aug 17, 2007 from CANADA Additional patient health information: Male patient , 71 years of age, weighting 224.0 lb, was diagnosed with hypertension and. Tiazac dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), TEMAZEPAM (View Temazepam Review and Temazepam Label ), AMILORIDE HCL AND HYDROCHLOROTHIAZIDE (View Amiloride Hcl And Hydrochlorothiazide Review and Amiloride Hcl And Hydrochlorothiazide Label ), ZAROXOLYN (View Zaroxolyn Review and Zaroxolyn Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), TAMOXIFEN (View Tamoxifen Review and Tamoxifen Label ), COUMADIN (View Coumadin Review and Coumadin Label ). Patient was hospitalized and became disabled.

5444115-8 | Bradycardia
Adverse event was reported on Aug 17, 2007 by a Female patient taking Tiazac (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: CANADA , 64 years of age, After Tiazac was administered, patient had the following side effects: bradycardia. Patient was hospitalized.

5444114-6 | Atrioventricular Block First Degree, Blood Pressure Decreased, Fatigue, Joint Swelling, Oedema Peripheral, Pulmonary Congestion, Transient Ischaemic Attack
on Aug 17, 2007 Female patient from CANADA , 49 years of age, was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block first degree, blood pressure decreased, fatigue, joint swelling, oedema peripheral, pulmonary congestion, transient ischaemic attack. Tiazac dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

5444112-2 | Fatigue, Heart Rate Decreased
on Aug 17, 2007 Male patient from CANADA , 58 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient had the following side effects: fatigue, heart rate decreased. Tiazac dosage: . During the same period patient was treated with TELMISARTAN (View Telmisartan Review and Telmisartan Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), COMBIVENT (ALBUTEROL/IPRATROPIUM) (View Combivent (albuterol/ipratropium) Review and Combivent (albuterol/ipratropium) Label ), SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ).

5444111-0 | Cellulitis, Oedema Peripheral
Patient was taking Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: cellulitis (What is cellulitis?), oedema peripheral on Aug 17, 2007 from CANADA Additional patient health information: Female patient , 61 years of age, . Tiazac dosage: . During the same period patient was treated with CEFAZOLIN SODIUM (View Cefazolin Sodium Review and Cefazolin Sodium Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ). Patient was hospitalized.

5444109-2 | Neck Pain
Adverse event was reported on Aug 17, 2007 by a Male patient taking Tiazac (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: CANADA , 50 years of age, Patient experienced the following unwanted or unexpected effects: neck pain. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

5444108-0 | Dyspnoea, Fatigue, Myocardial Ischaemia, Oedema Peripheral, Orthopnoea
on Aug 17, 2007 Male patient from CANADA , 49 years of age, weighting 216.1 lb, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient had the following side effects: dyspnoea, fatigue, myocardial ischaemia, oedema peripheral, orthopnoea. Tiazac dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5444079-7 | Cardiac Failure Congestive, Condition Aggravated, Hypertension, Myocardial Ischaemia
on Aug 17, 2007 Male patient from UNITED STATES , 62 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: cardiac failure congestive, condition aggravated, hypertension, myocardial ischaemia. Tiazac dosage: . During the same period patient was treated with ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5369391-1 | Cardiogenic Shock, Dizziness, Heart Rate Decreased, Nausea
Patient was taking Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, dizziness (What is dizziness?), heart rate decreased, nausea (What is nausea?) on Jun 15, 2007 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Tiazac dosage: . During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), COZAAR (View Cozaar Review and Cozaar Label ), CLODRONATE (View Clodronate Review and Clodronate Label ).

5369269-3 | Stevens-johnson Syndrome
Adverse event was reported on Jun 05, 2007 by a Male patient taking Tiazac (View Usage) (Dosage: 240 Mg Qd Po) . Location: UNITED STATES , 69 years of age, Patient had the following side effects: stevens-johnson syndrome. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ATROVENT (View Atrovent Review and Atrovent Label ), BRIMONIDINE TARTRATE (View Brimonidine Tartrate Review and Brimonidine Tartrate Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5309601-X | Cyanopsia, Optic Nerve Disorder, Visual Acuity Reduced, Xanthopsia
on Apr 11, 2007 Female patient from UNITED STATES , 73 years of age, was diagnosed with nervous system disorder, vasospasm and was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: cyanopsia, optic nerve disorder, visual acuity reduced, xanthopsia. Tiazac dosage: 720 Mg Qid Po. During the same period patient was treated with ZETIA (View Zetia Review and Zetia Label ), COZAAR (View Cozaar Review and Cozaar Label ), ALLEGRA (View Allegra Review and Allegra Label ).

5242160-9 | Blood Pressure Increased, Pharmaceutical Product Counterfeit
on Feb 05, 2007 Female patient from UNITED STATES , 60 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, pharmaceutical product counterfeit. Tiazac dosage: 180 Mg Qd Po.

5224735-6 | Blood Pressure Increased, Pharmaceutical Product Counterfeit
Patient was taking Tiazac (View Usage). Patient had the following side effects: blood pressure increased, pharmaceutical product counterfeit on Jan 29, 2007 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 160.0 lb, was diagnosed with blood pressure (What is blood pressure?) and. Tiazac dosage: 1 Tablet Daily Orally. Patient was hospitalized.

5215795-7 | Blood Pressure Fluctuation, Dizziness, Heart Rate Increased, Middle Insomnia
Adverse event was reported on Jan 04, 2007 by a Male patient taking Tiazac (View Usage) (Dosage: 180 Mg Qhs Po) was diagnosed with hypertension and. Location: UNITED STATES , 76 years of age, After Tiazac was administered, patient had the following side effects: blood pressure fluctuation, dizziness (What is dizziness?), heart rate increased, middle insomnia. During the same period patient was treated with TIAZAC XC (DILTIAZEM) (View Tiazac Xc (diltiazem) Review and Tiazac Xc (diltiazem) Label ), XATRAL (ALFUZOSIN) (View Xatral (alfuzosin) Review and Xatral (alfuzosin) Label ), APO ALLOPURINOL (ALLOPURINOL) (View Apo-allopurinol (allopurinol) Review and Apo-allopurinol (allopurinol) Label ), DIOVAN (View Diovan Review and Diovan Label ), NOVO PRAVASTATIN (View Novo-pravastatin Review and Novo-pravastatin Label ), VIAGRA (View Viagra Review and Viagra Label ).

5213031-9 | Cataract, Cyclitis, Intraocular Pressure Increased, Iritis
on Jan 09, 2007 Male patient from UNITED STATES , 68 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: cataract (What is cataract?), cyclitis, intraocular pressure increased, iritis. Tiazac dosage: 360 Mg Qd Po. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

5212585-6 | Blood Pressure Increased
on Jun 09, 2006 Male patient from UNITED STATES , 61 years of age, was diagnosed with blood pressure (What is blood pressure?) and was treated with Tiazac (View Usage). Patient had the following side effects: blood pressure increased. Tiazac dosage: 300 Mg Qd Po. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), MOEXIPRIL HCL (View Moexipril Hcl Review and Moexipril Hcl Label ), SOTALOL HYDROCHLORIDE (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

5207243-8 | Blood Pressure Increased, Dizziness, Hyperhidrosis, Nausea
Patient was taking Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: blood pressure increased, dizziness (What is dizziness?), hyperhidrosis, nausea (What is nausea?) on Jan 04, 2007 from UNITED STATES Additional patient health information: Female patient , 90 years of age, was diagnosed with hypertension and. Tiazac dosage: . During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), MULTIVITAMIN (NOS) (View Multivitamin (nos) Review and Multivitamin (nos) Label ), OMEGA 3 (FISH OIL) (View Omega 3 (fish Oil) Review and Omega 3 (fish Oil) Label ).

5203483-2 | Blood Pressure Fluctuation, Dizziness, Heart Rate Increased
Adverse event was reported on Dec 26, 2006 by a Male patient taking Tiazac (View Usage) (Dosage: 180 Mg Qhs Po) was diagnosed with hypertension and. Location: CANADA , 76 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure fluctuation, dizziness (What is dizziness?), heart rate increased. During the same period patient was treated with TIAZAC XC (DILTIAZEM) (View Tiazac Xc (diltiazem) Review and Tiazac Xc (diltiazem) Label ), XATRAL (ALFUZOSIN) (View Xatral (alfuzosin) Review and Xatral (alfuzosin) Label ), APO ALLOPURINOL (ALLOPURINOL) (View Apo-allopurinol (allopurinol) Review and Apo-allopurinol (allopurinol) Label ), DIOVAN (View Diovan Review and Diovan Label ), NOVO PRAVASTATIN (View Novo-pravastatin Review and Novo-pravastatin Label ).

5185328-2 | Asthenia, Dehydration, Erythema Multiforme, Feeling Hot, Hyperglycaemia, Paraesthesia, Post Inflammatory Pigmentation Change
on Jul 19, 2005 Female patient from UNITED STATES , 72 years of age, weighting 518.1 lb, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient had the following side effects: asthenia, dehydration, erythema multiforme, feeling hot, hyperglycaemia, paraesthesia, post inflammatory pigmentation change. Tiazac dosage: 180 Mg Qhs Po. During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), MICARDIS HCT (View Micardis Hct Review and Micardis Hct Label ), ZYRTEC (CETIRIZINE HYRDOCHLORIDE) (View Zyrtec (cetirizine Hyrdochloride) Review and Zyrtec (cetirizine Hyrdochloride) Label ), ACCUPRIL (View Accupril Review and Accupril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ). Patient was hospitalized.

5156466-5 | Atelectasis, Blood Creatinine Increased, Blood Urea Increased, Crepitations, Dehydration, Fatigue, Glomerular Filtration Rate Decreased, Hypertension
on Oct 30, 2006 Male patient from UNITED STATES , 82 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?), hypertension and was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: atelectasis, blood creatinine increased, blood urea increased, crepitations, dehydration, fatigue, glomerular filtration rate decreased, hypertension. Tiazac dosage: 120 Mg Tid Po. During the same period patient was treated with RAMIPRIL (10 Mg Qd) (View Ramipril Review and Ramipril Label ), HYDROCHLOROTHIAZIDE (25 Mg Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5126529-9 | Atelectasis, Blood Creatinine Increased, Blood Urea Increased, Cardiac Failure Congestive, Dehydration, Glomerular Filtration Rate Decreased, Oedema Peripheral, Pitting Oedema
Patient was taking Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: atelectasis, blood creatinine increased, blood urea increased, cardiac failure congestive, dehydration, glomerular filtration rate decreased, oedema peripheral, pitting oedema on Sep 29, 2006 from UNITED STATES Additional patient health information: Male patient , 82 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?), hypertension and. Tiazac dosage: 120 Mg Tid Po. During the same period patient was treated with RAMIPRIL (10 Mg Qd) (View Ramipril Review and Ramipril Label ), HYDROCHLOROTHIAZIDE (25 Mg Qd) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ).

5103643-5 | Atelectasis, Blood Creatinine Increased, Blood Urea Increased, Cardiac Failure Congestive, Dehydration, Fatigue, Rales, Weight Increased
Adverse event was reported on Aug 30, 2006 by a Male patient taking Tiazac (View Usage) (Dosage: 120 Mg Tid Po) was diagnosed with coronary artery disease (What is coronary artery disease?), hypertension and. Location: UNITED STATES , 82 years of age, Patient had the following side effects: atelectasis, blood creatinine increased, blood urea increased, cardiac failure congestive, dehydration, fatigue, rales, weight increased. During the same period patient was treated with RAMIPRIL (10 Mg Qd) (View Ramipril Review and Ramipril Label ), HYDROCHLOROTHIAZDE TAB (25 Mg Qd) (View Hydrochlorothiazde Tab Review and Hydrochlorothiazde Tab Label ), VALIUM (View Valium Review and Valium Label ), PERCOCET (View Percocet Review and Percocet Label ).

5097768-0 | Atrioventricular Block First Degree, Blood Pressure Decreased, Fatigue, Oedema Peripheral, Pulmonary Congestion, Transient Ischaemic Attack
on Aug 23, 2006 Female patient from CANADA , 49 years of age, was treated with Tiazac (View Usage). After Tiazac was administered, patient had the following side effects: atrioventricular block first degree, blood pressure decreased, fatigue, oedema peripheral, pulmonary congestion, transient ischaemic attack. Tiazac dosage: 360 Mg Qd Po. During the same period patient was treated with PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ).

5086487-2 | Bradycardia
on Aug 11, 2006 Female patient from CANADA , 64 years of age, was diagnosed with hypertension and was treated with Tiazac (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia. Tiazac dosage: 180 Mg Qd Po. Patient was hospitalized.

5085831-X | Cataract, Cyclitis, Intraocular Pressure Increased, Iritis
Patient was taking Tiazac (View Usage). Patient had the following side effects: cataract (What is cataract?), cyclitis, intraocular pressure increased, iritis on Aug 08, 2006 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with hypertension and. Tiazac dosage: 360 Mg Qd Po. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).